Kalayoglu Murat has filed 17 insider transactions across 1 company since November 2023.
Most recent transaction: a grant/award of 7800 shares of Cartesian Therapeutics, Inc. ($RNAC) on January 02, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Cartesian Therapeutics, Inc. | $RNAC | Kalayoglu Murat | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 26,003,606 | 9999.99% | 0.03% |
| Jan. 2, 2026 | Cartesian Therapeutics, Inc. | $RNAC | Kalayoglu Murat | Director | A | Common Stock | 2600 | $0.00 | 5,066,837.0000 | 26,003,606 | 0.05% | 0.01% |
| Jan. 2, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Kalayoglu Murat | Director | A | Common Stock | 2600 | $0.00 | 5,064,237.0000 | 25,767,369 | 0.05% | 0.01% |
| Jan. 2, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Kalayoglu Murat | Director | A | Stock Option (Right to Buy) | 7800 | $0.00 | 7,800.0000 | 25,767,369 | 9999.99% | 0.03% |
| Oct. 11, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Kalayoglu Murat | Director | M | Common Stock | 1518373 | $0.00 | 5,061,637.0000 | 23,896,525 | 42.85% | 6.35% |
| Oct. 11, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Kalayoglu Murat | Director | M | Series A Non-Voting Convertible Preferred Stock | 45551 | $0.00 | 56,402.2540 | 23,896,525 | 44.68% | 0.19% |
| April 8, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Kalayoglu Murat | Director | M | Series A Non-Voting Convertible Preferred Stock | 14756 | $0.00 | 101,953.4440 | 5,515,836 | 12.64% | 0.27% |
| April 8, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Kalayoglu Murat | Director | M | Series A Non-Voting Convertible Preferred Stock | 87803 | $0.00 | 101,953.4440 | 5,515,836 | 46.27% | 1.59% |
| April 8, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Kalayoglu Murat | Director | M | Common Stock | 491853 | $0.00 | 3,543,264.0000 | 5,515,836 | 16.12% | 8.92% |
| April 8, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Kalayoglu Murat | Director | M | Common Stock | 2926764 | $0.00 | 3,543,264.0000 | 5,515,836 | 474.74% | 53.06% |
| Jan. 2, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Kalayoglu Murat | Director | A | Stock Option (Right to Buy) | 228000 | $0.00 | 228,000.0000 | 5,397,597 | 9999.99% | 4.22% |
| Jan. 2, 2024 | Cartesian Therapeutics, Inc. | $RNAC | Kalayoglu Murat | Director | A | Common Stock | 178000 | $0.00 | 3,739,438.0000 | 5,397,597 | 5.00% | 3.30% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Kalayoglu Murat | Director | A | Series A Non-Voting Convertible Preferred Stock | 14756 | $0.00 | 15,375.2360 | 5,101,459 | 2381.37% | 0.29% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Kalayoglu Murat | Director | A | Common Stock | 257739 | $0.00 | 3,561,438.0000 | 5,101,459 | 7.80% | 5.05% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Kalayoglu Murat | Director | P | Series A Non-Voting Convertible Preferred Stock | 620 | $249999.98 | 15,375.2360 | 5,101,459 | 4.20% | 0.01% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Kalayoglu Murat | Director | J | Series A Non-Voting Convertible Preferred Stock | 189137 | $0.00 | 203,892.3760 | 5,101,459 | 1281.80% | 3.71% |
| Nov. 13, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Kalayoglu Murat | Director | J | Common Stock | 3303699 | $0.00 | 3,561,438.0000 | 5,101,459 | 1281.80% | 64.76% |